Company News

Dermatology Provider Ever/Body To Roll Out Its Own Skin Care Products

Will use $38M Series B to expand locations and offer its own prescription treatments.

Author Image

By: Christine Esposito

Editor-in-Chief

Ever/Body, a company that calls itself a “cosmetic dermatology provider of personalized, tech-enabled services,” has raised $38 million in Series B funding, consisting of both venture equity and debt.    The new funding will support Ever/Body's omni channel strategy, including market expansion, with the planned opening of multiple brick and mortar locations.  In addition, the company says it will roll out a line of branded prescription dermatology products, aimed at addressing key conc...

Continue reading this story and get 24/7 access to Happi for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Happi Newsletters